Cybernetic Model Design for the Qualification of Pharmaceutical Facilities
Source abstract
Abstract
In this paper, an integrated cybernetic model for managing qualification activities when commissioning pharmaceutical facilities is created, focusing on defining critical factors that provide all the prerequisites for the start of the production process. An eight-year research and work on complex projects in the pharmaceutical industry is integrated into a scientific research endeavor focused on the qualification of pharmaceutical facilities. The newly designed cybernetic model for the qualification of pharmaceutical facilities is flexible and adaptive and has the most adequate elements so far recognized in practice and enables the qualification of smart facilities, in accordance with the concept of Pharma 4.0. Additionally, it meets the requirements of the regulatory authorities; therefore, it constantly initiates the search for better solutions and process improvements. Moreover, it is universal and, thus, applicable to all reconstructions in the pharmaceutical industry. The application of the designed model has been implemented in practice and has shown outstanding results, as it combines diversity and sustainability in project management. Also, the model focuses on indicating aspects that include risk management, scientific approach, experimental testing, numerical simulations, as well as the possibility of optimization and energy saving.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Complex Systems and Decision Making
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Hemofarm, 26300 Vrsac, Serbia
Faculty of Mechanical Engineering, University of Belgrade, 11000 Belgrade, Serbia
References (56)
Show source-provided references
1. EudraLex The Rules Governing Medicinal Products in the European Union (2010). EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use, EudraLex The Rules Governing Medicinal Products in the European Union.
2. How to accelerate digital transformation in companies with Lean Philosophy? Contributions based on a practical case10.24867/IJIEM-2023-2-326 ↗
3. Adaptations of Pharma 4.0 from Industry 4.0
4. EudraLex The Rules Governing Medicinal Products in the European Union (2010). EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use–Annex 15: Qualification and Validation, EudraLex The Rules Governing Medicinal Products in the European Union.
5. Blackburn, T.D. (2024, June 20). Commissioning Fundamentals and a Practical Approach, PDH online Course, MBA, P146, 5272 Meadow Estates Drive. Available online: https://pdhonline.com/courses/p146/p146_new.htm.
6. The interplay of emerging technologies in pharmaceutical supply chain performance: An empirical investigation for the rise of Pharma 4.010.1016/j.techfore.2022.121768 ↗
7. ISPE (1994). GAMP Guide, International Society for Pharmaceutical Engineering.
8. (2012). Standard Guide for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and Equipment (Standard No. ASTM E2500-07).
9. Review on Pharmaceutical Validation and Its Implication
10. Render, N. (2006). The Validation of Pharmaceutical Buildings, University of Northumbria.
11. Project Management Institute (2021). Guide to the Project Management Body of Knowledge (PMBOK Guide) and The Standard for Project Management, Project Management Institute, Inc.. [7th ed.].
12. Horsley, D.M.C. (1998). Process Plant Commissioning: A User Guide, Institute of Chemical Engineers.
13. Integration as a project management concept: A study of the commissioning process in industrial deliveries10.1016/j.ijproman.2007.02.005 ↗
14. Project management for chemical engineers10.1205/ece06019 ↗
15. Sohmen, V.S. (1992). Capital project commissioning: Factors for success. Proceedings of the 36th Annual Transactions of the American Association of Cost Engineers, American Association of Cost Engineers: Morgantown.
16. Tabasevic, I., and Milanovic, D.D. (2020, January 8–9). The study of factors affecting the qualification of pharmaceutical facilities. Proceedings of the International Conference Industrial Engineering and Environmental Protection—IIZS 2020, Zrenjanin, Serbia.
17. ISPE (2019). Baseline Guide: Commissioning & Qualification, International Society for Pharmaceutical Engineering. [2nd ed.].
18. Brief overview of pharmaceutical facility validation10.33786/JCPR.2014.v04i02.004 ↗
19. A brief review on pharmaceutical validation10.52711/2231-5675.2022.00035 ↗
20. Demand of pharmaceutical facility functionality: Validation and qualification of HVAC system
21. (2019). Cleanrooms and associated controlled environments—Part 3: Test methods (Standard No. ISO 14644-3:2019).
22. Computer system validation in the perspective of the pharmaceutical industry10.22270/jddt.v8i6-s.2102 ↗
23. Importance of qualification, computer system validation and its regulatory compliance in pharmaceutical industry
24. Tabašević, I., Milanović, D., and Misita, M. (2018, January 27–28). Assessment of the scope of testing required to qualification the BMS using FMEA methods. Proceedings of the 7th International Symposium of Industrial Engineering—SIE, Belgrade, Serbia.
25. Execution & qualification of heating, ventilation and air conditioning system
26. Research of the scope of testing required for qualification of the hvac system
27. ISPE (2022). GAMP 5 Guide: A Risk-Based Approach to Compliant GxP Computerized Systems, International Society for Pharmaceutical Engineering.
28. Important project management knowledge areas for successful delivery of projects in pharmaceutical industry
29. Role of Project Manager in Pharmaceutical Industry10.32628/IJSRST1254122 ↗
30. Managing pharmaceuticals and life sciences projects on a global scale: A project management perspective10.4172/1948-593X.1000173 ↗
31. Joint optimization of production, maintenance, and quality: A review and research trends10.24867/IJIEM-2023-4-339 ↗
32. Personnel training for pharmaceutical industry
33. Slavic, D., Marjanovic, U., Medic, N., Simeunovic, N., and Rakic, S. (2024). The Evaluation of Industry 5.0 Concepts: Social Network Analysis Approach. Appl. Sci., 14.10.3390/app14031291 ↗
34. Current perspectives on the development of industry 4.0 in the pharmaceutical sector
35. (2023). ICH Guidance for Industry Q9 (R1) Quality Risk Management, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
36. Risk Management of HVAC System in Pharma Industries
37. A risk assessment approach: Qualification of a hvac system in aseptic processing area using building management system10.1002/qaj.485 ↗
38. A new approach in identifying and evaluating quality risks in the pharmaceutical industry
39. EudraLex The Rules Governing Medicinal Products in the European Union (2022). EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use–Annex 1: Manufacture of Sterile Medicinal Products, European Union.
40. (2023). Technical Report No. 90: Contamination Control Strategy Development, Parenteral Drug Association.
41. A total productive maintenance & reliability framework for an active pharmaceutical ingredient plant utilising design for Lean Six Sigma10.1016/j.heliyon.2023.e20516 ↗
42. A total productive maintenance (TPM) approach to improve production efficiency and development of loss structure in a pharmaceutical industry
43. Implementation of Total Productive Maintenance and Lean Manufacturing in the Pharmaceutical Industry: An Empirical Study10.32996/jbms.2023.5.3.10 ↗
44. Total productive maintenance (TPM) implementation in a machine shop: A case study10.1016/j.proeng.2013.01.084 ↗
45. Experimental and numerical investigation of thermal and flow conditions inside a large pharmaceutical storage after the ventilation system failure
46. Cleanroom Energy Efficiency
47. Effects of different air change rates on cleanroom ‘in operation’ status10.1080/03639045.2022.2043352 ↗
48. Computational pharmaceutics-A new paradigm of drug delivery10.1016/j.jconrel.2021.08.030 ↗
49. US Food and Drug Administration (2018). Standardization of Data and Documentation Practices for Product Tracing Guidance for Industry.
50. (2010). EudraLex The Rules Governing Medicinal Products in the European Union Volume 4. EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use–Chapter 4: Documentation, European Union.
51. Strategy to avoid data integrity issues in pharmaceutical industry
52. Kulkarni, P., and Kothari, C. (2024). Documentation and Data Integrity in Pharmaceutical Industry. Modern Aspects of Pharmaceutical Quality Assurance: Developing & Proposing Application Models, SOPs, Practical Audit Systems for Pharma Industry, Springer.10.1007/978-981-99-9271-3_11 ↗
53. Kavasidis, I., Lallas, E., Leligkou, H.C., Oikonomidis, G., Karydas, D., Gerogiannis, V.C., and Karageorgos, A. (2023). Deep Transformers for Computing and Predicting ALCOA+ Data Integrity Compliance in the Pharmaceutical Industry. Appl. Sci., 13.10.3390/app13137616 ↗
54. Bhusari, V., Potdar, M., Nandalwar, P., Warbhe, P., and Ghante, M. (2024). Developing a Design Qualification Protocol as Standard Operating Procedure for a Pharmaceutical Plant Facility Meeting cGMP Requirement for Tablets and Capsules Manufacturing Department. Modern Aspects of Pharmaceutical Quality Assurance: Developing & Proposing Application Models, SOPs, Practical Audit Systems for Pharma Industry, Springer.10.1007/978-981-99-9271-3_8 ↗
55. Internationa practices on GMP in pharmaceuticals
56. Edik, M. (2024). GMP Audits in Pharmaceutical and Biotechnology Industries, CRC Press.10.1201/9781003284970 ↗